Is fatigue in Marfan syndrome related to orthostatic intolerance?

  • Nynke van Dijk
  • Mardi C. Boer
  • Barbara J. M. Mulder
  • Gert A. van Montfrans
  • Wouter Wieling


Patients with Marfan syndrome have a tall stature, which could be associated with low orthostatic tolerance. Fatigue, a common complaint of these patients, is also related to orthostatic intolerance. Treatment with beta-blockers, to prevent aortic complications, could be a reinforcing factor of both. This study aimed to investigate (1) the relationship between symptoms of orthostatic tolerance and in patients with Marfan syndrome, and (2) whether termination of beta-blocker therapy improves orthostatic tolerance. Symptoms of fatigue and orthostatic complaints were assessed in 49 subjects using questionnaires (MFI-20 and Autonomic Symptoms Profile). Marfan patients have a high level of fatigue and orthostatic complaints when compared to the general population. Fatigue and orthostatic tolerance are significantly correlated. Orthostatic tolerance was assessed in 9 additional subjects by an active-standing test and head-up tilt for 5 minutes, and 24 hours blood pressure monitoring, once during beta-blocker therapy and once after ceasing beta-blockers for 2 weeks. During hemodynamic testing Marfan patients frequently showed Initial Orthostatic Hypotension and an abnormally high initial heart rate response. Ceasing beta-blockers did not affect the initial blood pressure response. Patients with Marfan syndrome are fatigued and have low orthostatic tolerance, which are significantly correlated. Patients could be educated in physical counterpressure maneuvers to increase orthostatic tolerance.


Marfan syndrome orthostatic tolerance fatigue blood pressure 


  1. 1.
    Arnsdorf MF (2006) Normal sinus rhythm and sinus arrhythmia. UpToDate Version 14.1.2006 (15-6-2006)Google Scholar
  2. 2.
    Bou-Holaigah I, Rowe PC, Kan J, Calkins H (1995) The relationship between neurally mediated hypotension and the chronic fatigue syndrome. JAMA 274:961–967PubMedCrossRefGoogle Scholar
  3. 3.
    Calkins H, Shyr Y, Frumin H, Schork A, Morady F (1995) The value of the clinical history in the differentiation of syncope due to ventricular tachycardia, atrioventricular block, and neurocardiogenic syncope. Am J Med 98:365–373PubMedCrossRefGoogle Scholar
  4. 4.
    Cohn RD, van EC, Habashi JP, Soleimani AA, Klein EC, Lisi MT, Gamradt M, ap Rhys CM, Holm TM, Loeys BL, Ramirez F, Judge DP, Ward CW, Dietz HC (2007) Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Nat Med 13:204–210PubMedCrossRefGoogle Scholar
  5. 5.
    Colman N, Nahm K, van Dijk JG, Reitsma JB, Wieling W, Kaufmann H (2004) Diagnostic value of history taking in reflex syncope. Clin Auton Res 14(Suppl 1):i37–i44CrossRefGoogle Scholar
  6. 6.
    De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE (1996) Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 62:417–426PubMedCrossRefGoogle Scholar
  7. 7.
    Groenink M, de Roos A, Mulder BJ, Spaan JA, van der Wall EE (1998) Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome. Am J Cardiol 82:203–208PubMedCrossRefGoogle Scholar
  8. 8.
    Imholz BP, Wieling W, van Montfrans GA, Wesseling KH (1998) Fifteen years experience with finger arterial pressure monitoring: assessment of the technology. Cardiovasc Res 38:605–616PubMedCrossRefGoogle Scholar
  9. 9.
    Jellema WT, Imholz BP, van GJ, Wesseling KH, van Lieshout JJ (1996) Finger arterial versus intrabrachial pressure and continuous cardiac output during head-up tilt testing in healthy subjects. Clin Sci (Lond) 91:193–200Google Scholar
  10. 10.
    Kaufmann H, Kaplan NM, Freeman R (2006) Mechanisms and causes of orthostatic and postprandial hypotension. UpToDate Version 14.1.2006 (2-3-2006)Google Scholar
  11. 11.
    Ko DT, Hebert PR, Coffey CS, Sedrakyan A, Curtis JP, Krumholz HM (2002) Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 288:351–357PubMedCrossRefGoogle Scholar
  12. 12.
    Krediet CT, Go-Schon IK, Kim YS, Linzer M, van Lieshout JJ, Wieling W (2007) Management of initial orthostatic hypotension: lower body muscle tensing attenuates the transient arterial blood pressure decrease upon standing from squatting. Clin Sci (Lond) 113:401–407Google Scholar
  13. 13.
    Lewis T (1932) Vasovagal syncope and the carotid sinus mechanism. BMJ 873–876Google Scholar
  14. 14.
    Ludwig DA, Convertino VA (1994) Predicting orthostatic intolerance: physics or physiology? Aviat Space Environ Med 65:404–411PubMedGoogle Scholar
  15. 15.
    Meijboom LJ, Westerhof BE, Nollen GJ, Spaan JA, de Mol BA, Jacobs MJ, Mulder BJ (2004) Beta-blocking therapy in patients with the Marfan syndrome and entire aortic replacement. Eur J Cardiothorac Surg 26:901–906PubMedCrossRefGoogle Scholar
  16. 16.
    O’Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, Myers M, Padfield P, Palatini P, Parati G, Pickering T, Redon J, Staessen J, Stergiou G, Verdecchia P (2005) Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 23:697–701PubMedCrossRefGoogle Scholar
  17. 17.
    Peters KF, Horne R, Kong F, Francomano CA, Biesecker BB (2001) Living with Marfan syndrome II. Medication adherence and physical activity modification. Clin Genet 60:283–292PubMedCrossRefGoogle Scholar
  18. 18.
    Peters KF, Kong F, Horne R, Francomano CA, Biesecker BB (2001) Living with Marfan syndrome I. Perceptions of the condition. Clin Genet 60:273–282PubMedCrossRefGoogle Scholar
  19. 19.
    Pyeritz RE (1990) Marfan syndrome. In: Emery AEH, Rimoin DL (eds) Principles and practice of medical genetics. Churchill Livingstone, New York, pp 1047–1063Google Scholar
  20. 20.
    Rand-Hendriksen S, Sorensen I, Holmstrom H, Andersson S, Finset A (2007) Fatigue, cognitive functioning and psychological distress in Marfan syndrome, a pilot study. Psychol Health Med 12:305–313PubMedCrossRefGoogle Scholar
  21. 21.
    Rowe PC, Barron DF, Calkins H, Maumenee IH, Tong PY, Geraghty MT (1999) Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers-Danlos syndrome. J Pediatr 135:494–499PubMedCrossRefGoogle Scholar
  22. 22.
    Rowe PC, Calkins H, DeBusk K, McKenzie R, Anand R, Sharma G, Cuccherini BA, Soto N, Hohman P, Snader S, Lucas KE, Wolff M, Straus SE (2001) Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial. JAMA 285:52–59PubMedCrossRefGoogle Scholar
  23. 23.
    Shapiro JR, Wright MJ (2006) The Marfan syndrome. UpToDate version 14.1.2006 (2-3-2006)Google Scholar
  24. 24.
    Shores J, Berger KR, Murphy EA, Pyeritz RE (1994) Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan’s syndrome. N Engl J Med 330:1335–1341PubMedCrossRefGoogle Scholar
  25. 25.
    Smets EM, Garssen B, Bonke B (1995) The measurement of fatigue with the multidimensional fatigue inventory (MFI-20). A manual. Medical Psychology, Academic Medical Center, University of AmsterdamGoogle Scholar
  26. 26.
    Smets EM, Garssen B, Bonke B, De Haes JC (1995) The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39:315–325PubMedCrossRefGoogle Scholar
  27. 27.
    Smets EM, Visser MR, Willems-Groot AF, Garssen B, Schuster-Uitterhoeve AL, De Haes JC (1998) Fatigue and radiotherapy: (B) experience in patients 9 months following treatment. Br J Cancer 78:907–912PubMedGoogle Scholar
  28. 28.
    Staessen JA, Beilin L, Parati G, Waeber B, White W (1999) Task force IV: clinical use of ambulatory blood pressure monitoring. Participants of the 1999 Consensus Conference on Ambulatory Blood Pressure Monitoring. Blood Press Monit 4:319–331PubMedGoogle Scholar
  29. 29.
    Staessen JA, Fagard RH, Lijnen PJ, Thijs L, Van HR, Amery AK (1991) Mean and range of the ambulatory pressure in normotensive subjects from a meta-analysis of 23 studies. Am J Cardiol 67:723–727PubMedCrossRefGoogle Scholar
  30. 30.
    Suarez GA, Opfer-Gehrking TL, Offord KP, Atkinson EJ, O’Brien PC, Low PA (1999) The autonomic symptom profile: a new instrument to assess autonomic symptoms. Neurology 52:523–528PubMedGoogle Scholar
  31. 31.
    Tanaka H, Matsushima R, Tamai H, Kajimoto Y (2002) Impaired postural cerebral hemodynamics in young patients with chronic fatigue with and without orthostatic intolerance. J Pediatr 140:412–417PubMedCrossRefGoogle Scholar
  32. 32.
    van Dijk N, Immink RV, Mulder BJ, van Lieshout JJ, Wieling W (2005) Orthostatic blood pressure control in Marfan’s syndrome. Europace 7:25–27PubMedGoogle Scholar
  33. 33.
    van Dijk N, Quartieri F, Blanc JJ, Garcia-Civera R, Brignole M, Moya A, Wieling W, on behalf of the PC-Trial investigators (2006) Effectiveness of physical counterpressure manoeuvres in preventing vasovagal syncope. The Physical Counterpressure manoeuvre Trial (PC-Trial). J Am Coll Cardiol 48:1652–1657PubMedGoogle Scholar
  34. 34.
    Wieling W, Karemaker JM (1992) Measurement of heart rate and blood pressure to evaluate disturbances in neurocardiovascular control. In: Bannister R, Mathias CJ (eds) Autonomic failure: a textbook of clinical disorders of the autonomic nervous system. Oxford University Press, Oxford, pp 196–210Google Scholar
  35. 35.
    Wieling W, Krediet CT, van Dijk N, Linzer M, Tschakovsky ME (2007) Initial orthostatic hypotension: review of a forgotten condition. Clin Sci (Lond) 112:157–165CrossRefGoogle Scholar
  36. 36.
    Wyller VB, Saul JP, Walloe L, Thaulow E (2008) Sympathetic cardiovascular control during orthostatic stress and isometric exercise in adolescent chronic fatigue syndrome. Eur J Appl Physiol 102:623–632PubMedCrossRefGoogle Scholar
  37. 37.
    Wyller VB, Thaulow E, Amlie JP (2007) Treatment of chronic fatigue and orthostatic intolerance with propranolol. J Pediatr 150:654–655PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2008

Authors and Affiliations

  • Nynke van Dijk
    • 1
    • 2
  • Mardi C. Boer
    • 3
  • Barbara J. M. Mulder
    • 4
  • Gert A. van Montfrans
    • 3
  • Wouter Wieling
    • 3
  1. 1.Dept. of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical CentreUniversity of AmsterdamAmsterdamThe Netherlands
  2. 2.Dept. of KEBB, J1b-210-1Academic Medical CentreAmsterdamThe Netherlands
  3. 3.Dept. of Internal Medicine, Academic Medical CentreUniversity of AmsterdamAmsterdamThe Netherlands
  4. 4.Dept. of Cardiology, Academic Medical CentreUniversity of AmsterdamAmsterdamThe Netherlands

Personalised recommendations